Federal Judge Signals Possible Dismissal of xAI Lawsuit Against OpenAI 
DOJ Urges Judge to Block Lawmakers’ Bid for Special Master in Jeffrey Epstein Records Case 
Qantas to Sell Jetstar Japan Stake as It Refocuses on Core Australian Operations 
NRW Holdings Shares Surge After Securing Major Rio Tinto Contract and New Project Wins 
Gold, Silver, and Platinum Rally as Precious Metals Recover from Sharp Selloff 
FDA Approves Mitapivat for Anemia in Thalassemia Patients 
US Judge Rejects $2.36B Penalty Bid Against Google in Privacy Data Case 
Oracle Plans $45–$50 Billion Funding Push in 2026 to Expand Cloud and AI Infrastructure 
Sam Altman Reaffirms OpenAI’s Long-Term Commitment to NVIDIA Amid Chip Report 
SpaceX Reports $8 Billion Profit as IPO Plans and Starlink Growth Fuel Valuation Buzz 
New York Judge Orders Redrawing of GOP-Held Congressional District 
Nvidia Confirms Major OpenAI Investment Amid AI Funding Race 
Bob Iger Plans Early Exit as Disney Board Prepares CEO Succession Vote 
Sanofi to Acquire Dynavax in $2.2 Billion Deal to Strengthen Vaccine Portfolio 
South Korea Inflation Hits Five-Month Low as CPI Reaches Central Bank Target 
Nvidia’s $100 Billion OpenAI Investment Faces Internal Doubts, Report Says 
Johnson & Johnson (J&J) has sued drug distributors and a pharmacy seeking to stop the sale of counterfeit versions of its HIV drugs, and at least $25 million in damages from each defendant.
Patients complaining about receiving the wrong pills in their prescription bottles led J&J to discover widespread counterfeiting, as did the voluntary return of hundreds of bottles of counterfeit pharmaceuticals from one of the defendants, distributor ProPharma Distribution LLC.
Following Gilead Sciences Inc.'s lawsuit in January, the firm said it became aware of the sale of counterfeit versions of its HIV medications. Symtuza, a multi-drug combination treatment, as well as Prezcobix, Prezista, and Edurant, are among the medications at issue.
J&J claims that counterfeit bottles occasionally included a different HIV medicine than what was advertised on the label and that one counterfeit bottle contained the strong antipsychotic Seroquel.
The defendants include ProPharma, Safe Chain Solutions LLC, and Scripts Wholesale Inc, as well as drugstore operator I Care Pharmacy 14 and the business' individual proprietors.
According to the lawsuit, I Care Pharmacy had a physical location in New York City that was closed down immediately after a fraudulent transaction was found.
J&J believes the pharmacy is linked to a criminal counterfeiting network that is still operational in New York City, dispensing hazardous counterfeit HIV medication.
